But drug trials are expensive, so an astonishing 90 percent of clinical drug trials, and 70 percent of trials reported in major medical journals, are conducted or commissioned by the pharmaceutical industry. A key feature of science is that findings should be replicated, but if only one organization is doing the funding, then this feature is lost.
